Biotech Stocks
Eli Lilly files first lawsuits over retatrutide 'black market'
Endpoints News
Aug 12, 2026
Eli Lilly has sued six US companies for selling what it claims is the pharma giant’s investigational diabetes and weight loss drug retatrutide, which is still undergoing clinical trials. The litigation is Lilly’s first involving ...
Discussion
Sign in to join the discussion. Comments loading…